These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 17384532

  • 1. Preliminary study on Japanese cedar pollinosis in an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K, Tang H, Fujita T, Tsubaki S, Fujita M, Suematsu K, Gotoh M, Okubo K.
    Allergol Int; 2007 Jun; 56(2):125-30. PubMed ID: 17384532
    [Abstract] [Full Text] [Related]

  • 2. Bepotastine besilate OD tablets suppress nasal symptoms caused by Japanese cedar pollen exposure in an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K, Tang H, Fujita T, Suematsu K, Gotoh M, Okubo K.
    Expert Opin Pharmacother; 2009 Mar; 10(4):523-9. PubMed ID: 19216705
    [Abstract] [Full Text] [Related]

  • 3. Validation study of the OHIO Chamber in patients with Japanese cedar pollinosis.
    Hashiguchi K, Tang H, Fujita T, Suematsu K, Tsubaki S, Nagakura H, Kitajima S, Gotoh M, Okubo K.
    Int Arch Allergy Immunol; 2009 Mar; 149(2):141-9. PubMed ID: 19127071
    [Abstract] [Full Text] [Related]

  • 4. Persistent nasal symptoms and mediator release after continuous pollen exposure in an environmental challenge chamber.
    Okuma Y, Okamoto Y, Yonekura S, Iinuma T, Sakurai T, Hamasaki S, Ohki Y, Yamamoto H, Sakurai D.
    Ann Allergy Asthma Immunol; 2016 Aug; 117(2):150-7. PubMed ID: 27263086
    [Abstract] [Full Text] [Related]

  • 5. Evaluating the effects of testing period on pollinosis symptoms using an allergen challenge chamber.
    Yuki A, Terada T, Ichihara T, Fujii K, Hyo S, Kawata R, Takenaka H.
    Allergol Int; 2011 Dec; 60(4):533-9. PubMed ID: 21918369
    [Abstract] [Full Text] [Related]

  • 6. Intranasal levels of lead as an exacerbation factor for allergic rhinitis in humans and mice.
    Xu H, Ohgami N, Sakashita M, Ogi K, Hashimoto K, Tazaki A, Tong K, Aoki M, Fujieda S, Kato M.
    J Allergy Clin Immunol; 2021 Jul; 148(1):139-147.e10. PubMed ID: 33766551
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of the Chiba environmental challenge chamber.
    Hamasaki S, Okamoto Y, Yonekura S, Okuma Y, Sakurai T, Iinuma T, Yamamoto H, Sakurai D, Horiguchi S, Yokota M.
    Allergol Int; 2014 Mar; 63(1):41-50. PubMed ID: 24368583
    [Abstract] [Full Text] [Related]

  • 8. Effect of antihistamine eye drops on the conjunctival provocation test with Japanese cedar pollen allergen.
    Dake Y, Enomoto T, Cheng L, Enomoto K, Shibano A, Ikeda H, Yoda S, Yajin S, Sakota T, Yamanishi E.
    Allergol Int; 2006 Dec; 55(4):373-8. PubMed ID: 17130679
    [Abstract] [Full Text] [Related]

  • 9. Evaluation of the efficacy and safety of olopatadine and fexofenadine compared with placebo in Japanese cedar pollinosis using an environmental exposure unit.
    Enomoto T, Lu HQ, Yin M, Sakoda T, Dake Y, Enomoto K, Ide T, Cheng L.
    J Investig Allergol Clin Immunol; 2009 Dec; 19(4):299-305. PubMed ID: 19639726
    [Abstract] [Full Text] [Related]

  • 10. Nasal and ocular responses after specific and nonspecific nasal challenges in seasonal allergic rhinitis.
    Tomljenovic D, Baudoin T, Megla ZB, Vagic D, Hellings P, Kalogjera L.
    Ann Allergy Asthma Immunol; 2016 Mar; 116(3):199-205. PubMed ID: 26804667
    [Abstract] [Full Text] [Related]

  • 11. [Is the frequency of pre-seasonal manifestation in patients with Japanese cedar pollinosis so high?].
    Okuda M, Ohkubo K, Gotoh M, Ishida Y.
    Arerugi; 2005 Jul; 54(7):636-40. PubMed ID: 16229363
    [Abstract] [Full Text] [Related]

  • 12. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure.
    Badorrek P, Müller M, Koch W, Hohlfeld JM, Krug N.
    Ann Allergy Asthma Immunol; 2017 Mar; 118(3):290-297. PubMed ID: 28284536
    [Abstract] [Full Text] [Related]

  • 13. Effects of antihistamine on up-regulation of histamine H1 receptor mRNA in the nasal mucosa of patients with pollinosis induced by controlled cedar pollen challenge in an environmental exposure unit.
    Kitamura Y, Nakagawa H, Fujii T, Sakoda T, Enomoto T, Mizuguchi H, Fukui H, Takeda N.
    J Pharmacol Sci; 2015 Nov; 129(3):183-7. PubMed ID: 26598006
    [Abstract] [Full Text] [Related]

  • 14. Pranlukast dry syrup inhibits symptoms of Japanese cedar pollinosis in children using OHIO Chamber.
    Wakabayashi K, Hashiguchi K, Kanzaki S, Fujioka M, Tanaka N, Kawashima K, Suematsu K, Yamamotoya H, Iwasaki M, Gotoh M, Horibe S, Naito K, Okubo K.
    Allergy Asthma Proc; 2012 Nov; 33(1):102-9. PubMed ID: 22370535
    [Abstract] [Full Text] [Related]

  • 15. Effect of intranasal corticosteroid on pre-onset activation of eosinophils and mast cells in experimental Japanese cedar pollinosis.
    Noyama Y, Okano M, Fujiwara T, Kariya S, Makihara S, Haruna T, Kanai K, Higaki T, Nishizaki K.
    Allergol Int; 2016 Jul; 65(3):259-65. PubMed ID: 26907728
    [Abstract] [Full Text] [Related]

  • 16. Effect of Asian sand dust on Japanese cedar pollinosis.
    Ogi K, Takabayashi T, Sakashita M, Susuki D, Yamada T, Manabe Y, Fujieda S.
    Auris Nasus Larynx; 2014 Dec; 41(6):518-22. PubMed ID: 24928063
    [Abstract] [Full Text] [Related]

  • 17. Japanese Cedar Pollen-Specific IgA in Nasal Secretions and Nasal Allergy Symptoms.
    Suzuki M, Yokota M, Ozaki S, Matsumoto T, Nakamura Y.
    Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):330-337. PubMed ID: 30678469
    [Abstract] [Full Text] [Related]

  • 18. Measurement of Japanese cedar pollen-specific IgE in nasal secretions.
    Sakaida H, Masuda S, Takeuchi K.
    Allergol Int; 2014 Sep; 63(3):467-73. PubMed ID: 24957114
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber).
    Hashiguchi K, Wakabayashi KI, Togawa M, Saito A, Okubo K.
    Allergol Int; 2017 Jan; 66(1):123-131. PubMed ID: 27475625
    [Abstract] [Full Text] [Related]

  • 20. Elevated levels of interleukin-33 in the nasal secretions of patients with allergic rhinitis.
    Asaka D, Yoshikawa M, Nakayama T, Yoshimura T, Moriyama H, Otori N.
    Int Arch Allergy Immunol; 2012 Jan; 158 Suppl 1():47-50. PubMed ID: 22627366
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.